CD3G and neoplasm: Specifically, ligand–receptor interactions related to antigen presentation machinery (e.g., HLA-A-CD3G and B2M-KLRD1) were mainly observed between intermediate tumor cells and almost all CD8+ T clusters (Figure 3A).